Patents by Inventor Jeremy Johnson

Jeremy Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140274577
    Abstract: A dual treadle treadmill. The dual treadle treadmill includes a frame, a first treadle, a second treadle, a clutch axle, and a tensioning mechanism. The first treadle and the second treadle are each pivotally coupled with the frame and each have a moving surface. The clutch axle includes an axle, a first driver, and a second driver. The axle is rotatably connected to the frame. The first driver is coupled to the axle by a first clutch. The first clutch transmits torque between the first driver and the axle in response to the first driver rotating in a first direction relative to the axle. The first treadle is connected to the first driver through a first link such that the first driver is rotated in a first direction in response to the first treadle being pivoted in the first direction. The tensioning mechanism maintains a tension on the first link.
    Type: Application
    Filed: March 12, 2013
    Publication date: September 18, 2014
    Inventors: David Beard, Kevin Corbalis, Victor Cornejo, Steve Neill, Jeremy Johnson, Jeff Lassegard
  • Publication number: 20140274576
    Abstract: A dual treadle treadmill. The dual treadle treadmill includes a frame, a first treadle, a second treadle, and a generator. The first treadle and the second treadle are each pivotally coupled with the frame and each have a moving surface. The generator is operably associated with the first treadle such that the generator is driven in response to the first treadle pivoting relative to the frame. Other embodiments of dual treadle treadmills are also described.
    Type: Application
    Filed: March 12, 2013
    Publication date: September 18, 2014
    Inventors: David Beard, Kevin Corbalis, Victor Cornejo, Steve Neill, Jeremy Johnson, Jeff Lassegard
  • Publication number: 20140222999
    Abstract: The invention relates to an application server and a method. The application server comprises a resolver which reserves a subscriber number prefix for test target applications. The resolver associates an address of an application server with the prefix in a memory and resolves subscriber numbers containing the prefix into the address using the memory. A network element simulator listens to a port, which has a port number which is also used in communicating with the network element being simulated. A test target application communicates with the simulator instead of the network element being simulated via a protocol stack in the application server. An application layer binding is used to route incoming messages to the test target application.
    Type: Application
    Filed: February 15, 2011
    Publication date: August 7, 2014
    Applicant: NOKIA SIEMENS NETWORKS OY
    Inventors: Duncan Sample, Jeremy Johnson, Carlos Manzanares Sancho, Irving Benjamin Cordova, Mikhael Harswanto Tanutama, Joao Martins, Ivo Rodrigues, Marc Heide, Tri Wasono Adi Nugroho, Konrad Garlikowski, Lukasz Jastrzebski, Beata Bartoszewska-Karas, Ahmer Javaid, Vaughn Eisler
  • Publication number: 20140068830
    Abstract: Garments are disclosed for use on the lower body, e.g., as an undergarment or athletic shorts or tights. The garments include a plurality of panels made of different materials that together help to protect the wearer and that are designed to enhance the wearer's comfort and performance. In some cases the panels are selected and configured to match the requirements of various body regions and contours.
    Type: Application
    Filed: June 4, 2013
    Publication date: March 13, 2014
    Inventor: Jeremy Johnson
  • Publication number: 20140038288
    Abstract: Cytotoxic variants of human ribonuclease 1 (RNase 1) identified through analysis of the interaction between RNase 1 and the human ribonuclease inhibitor (hRI) as defined by the three dimensional (3-D) atomic structure of the RNase1 hRI complex are disclosed. Also disclosed is the 3-D structure of the hRI.RNase 1 complex and methods for designing and using the RNase 1 variants.
    Type: Application
    Filed: October 4, 2013
    Publication date: February 6, 2014
    Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Ronald T. Raines, George N. Phillips, JR., R. Jeremy Johnson, Jason G. McCoy
  • Publication number: 20130297756
    Abstract: One example embodiment provides a method and system where a node in a utility network receives a block of IPv6 network addresses from an access point in the utility network. The utility node allocates an IP network address from the block of IPv6 network addresses received from the access point to an in-premise device which communicates to the utility node over an in-premise network which is not IP based. The utility node proxies the allocated IP address to the utility network, allowing other nodes on the utility network to address and communicate with the in-premise device.
    Type: Application
    Filed: July 2, 2013
    Publication date: November 7, 2013
    Inventors: Raj Vaswani, Jeremy Johnson, Jay Ramasastry
  • Patent number: 8569457
    Abstract: Cytotoxic variants of human ribonuclease 1 (RNase 1) identified through analysis of the interaction between RNase 1 and the human ribonuclease inhibitor (hRI) as defined by the three dimensional (3-D) atomic structure of the RNase1 hRI complex are disclosed. Also disclosed is the 3-D structure of the hRI·RNase 1 complex and methods for designing the RNase 1 variants.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: October 29, 2013
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Ronald T. Raines, George N. Phillips, Jr., R. Jeremy Johnson, Jason G. McCoy
  • Patent number: 8489716
    Abstract: One example embodiment provides a method and system where a node in a utility network receives a block of IPv6 network addresses from an access point in the utility network. The utility node allocates an IP network address from the block of IPv6 network addresses received from the access point to an in-premise device which communicates to the utility node over an in-premise network which is not IP based. The utility node proxies the allocated IP address to the utility network, allowing other nodes on the utility network to address and communicate with the in-premise device.
    Type: Grant
    Filed: May 24, 2007
    Date of Patent: July 16, 2013
    Assignee: Silver Spring Networks, Inc.
    Inventors: Raj Vaswani, Jeremy Johnson, Jay Ramasastry
  • Publication number: 20130156030
    Abstract: A method of distributing information to a plurality of nodes in a network. The method includes selecting a node of the plurality of nodes as a seed node, providing a patch image to the seed node, creating, by the seed node, a second image from the patch image, and disseminating the second image to a plurality of neighbor nodes.
    Type: Application
    Filed: December 16, 2011
    Publication date: June 20, 2013
    Inventors: Jeremy Johnson, Raj Vaswani, Kunal Shah
  • Publication number: 20130087340
    Abstract: Methods and systems are provided for favorably altering the chemomechanical properties of subterranean formations using treatment fluids comprising surfactants and halide salts. Methods for treating formations comprise the steps of introducing a chemomechanical treatment fluid into the formation and allowing the treatment fluid to interact with the formation to alter its petrochemical properties in various ways. Depending on the application, the chemomechanical treatment fluid may comprise a base fluid, a halide salt and an amphoteric or nonamphoteric surfactant where the surfactant is dissolved in the base fluid at a concentration below its critical micelle concentration. Applications of use involving the chemomechanical treatment fluids include treatment operations, secondary recovery operations, drilling operations, and any other operation that would benefit from the formation property modifications described herein.
    Type: Application
    Filed: December 19, 2011
    Publication date: April 11, 2013
    Applicant: CONOCOPHILLIPS COMPANY
    Inventors: Robert Charles Choens, II, Gangerico G. Ramos, Carl T. Montgomery, Jeremy Johnson
  • Publication number: 20130011904
    Abstract: Cytotoxic variants of human ribonuclease 1 (RNase 1) identified through analysis of the interaction between RNase 1 and the human ribonuclease inhibitor (hRI) as defined by the three dimensional (3-D) atomic structure of the RNase1 hRI complex are disclosed. Also disclosed is the 3-D structure of the hRI·RNase 1 complex and methods for designing the RNase 1 variants.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 10, 2013
    Applicant: Wisconsin Alumni Research Foundation
    Inventors: Ronald T. Raines, George N. Phillips, JR., R. Jeremy Johnson, Jason G. McCoy
  • Patent number: 8293872
    Abstract: This invention relates to cytotoxic variants of human ribonuclease 1 (RNase 1) identified through analysis of the interaction between RNase 1 and the human ribonuclease inhibitor (hRI) as defined by the three dimensional (3-D) atomic structure of the RNase1 hRI complex. Also disclosed is the 3-D structure of the hRI•RNase 1 complex and methods for designing the RNase 1 variants.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: October 23, 2012
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Ronald T. Raines, George N. Phillips, Jr., R. Jeremy Johnson, Jason G. McCoy
  • Patent number: 8230972
    Abstract: A tree stand including a first support secured to the tree and which has a platform secured thereto which may be adjustably positioned with respect to the first support to compensate for variously angled tree trunks or branches. A seat assembly is rotatably mounted on the platform so as to be movable 360° with respect to the platform.
    Type: Grant
    Filed: June 18, 2010
    Date of Patent: July 31, 2012
    Inventor: Jeremy Johnson
  • Publication number: 20120009173
    Abstract: This invention relates to cytotoxic variants of human ribonuclease 1 (RNase 1) identified through analysis of the interaction between RNase 1 and the human ribonuclease inhibitor (hRI) as defined by the three dimensional (3-D) atomic structure of the RNase1 hRI complex. Also disclosed is the 3-D structure of the hRI•RNase 1 complex and methods for designing the RNase 1 variants.
    Type: Application
    Filed: September 23, 2011
    Publication date: January 12, 2012
    Inventors: Ronald T. Raines, George N. Philllips, JR., R. Jeremy Johnson, Jason G. McCoy
  • Publication number: 20110308887
    Abstract: A tree stand including a first support secured to the tree and which has a platform secured thereto which may be adjustably positioned with respect to the first support to compensate for variously angled tree trunks or branches. A seat assembly is rotatably mounted on the platform so as to be movable 360° with respect to the platform.
    Type: Application
    Filed: June 18, 2010
    Publication date: December 22, 2011
    Inventor: Jeremy Johnson
  • Patent number: 8048425
    Abstract: This invention relates to cytotoxic variants of human ribonuclease 1 (RNase 1) identified through analysis of the interaction between RNase 1 and the human ribonuclease inhibitor (hRI) as defined by the three dimensional (3-D) atomic structure of the RNase1 hRI complex. Also disclosed is the 3-D structure of the hRI•RNase 1 complex and methods for designing the RNase 1 variants.
    Type: Grant
    Filed: July 2, 2009
    Date of Patent: November 1, 2011
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Ronald T. Raines, George N. Phillips, Jr., R. Jeremy Johnson, Jason G. McCoy
  • Patent number: 8021380
    Abstract: An obstruction removal system for percutaneous removal of clots or obstructions within the vascular system is disclosed. The obstruction removal system includes a multi-lumen catheter with a plurality of circulating capture devices attached to or integral with a drive belt. The circulating capture or interference devices affect removal of the clot or obstruction bit-by-bit through a series of passes. The obstruction removal system may include one or more drive mechanisms, such as a pulley system and/or a vacuum source and/or a pressurization source, on its proximal end for driving the drive belt and capture devices through the catheter in a circulating manner. The obstruction removal system may also include one or more cleaning mechanisms, such as a vacuum chamber and/or a fluid rinse chamber, for removing the captured clot pieces from the capture devices.
    Type: Grant
    Filed: January 11, 2008
    Date of Patent: September 20, 2011
    Inventors: Dustin Thompson, D. H. Perkins, Jeremy Johnson, Michele Silver, Kevin Mauch, Patrick Macaulay
  • Patent number: 7972271
    Abstract: An invention for coherent array image formation and restoration is taught. The invention is applicable for both 2D and 3D imaging using either 1D or 2D arrays, respectively. A transducer array is subdivided into subarrays, each subarray having a number of adjacent array elements. All elements of each subarray transmit and receive in parallel. The signals received from each subarray are delayed and summed to form scan lines, or beams. The low-beam-rate beams formed from each subarray are upsampled and interpolated prior to forming high-beam-rate images. Depending on the subarray geometry, a subarray-dependent restoration filter is also applied to the subarray beams. The restored beams from each subarray are combined to form the final high-beam-rate image. The invention significantly reduces the front-end hardware complexity compared to conventional methods such as full phased array imaging with comparable image quality.
    Type: Grant
    Filed: February 21, 2007
    Date of Patent: July 5, 2011
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Jeremy Johnson, Mustafa Karaman, Butrus T. Khuri-Yakub
  • Publication number: 20100047210
    Abstract: Systems and methods for delivering a substance (e.g., a therapeutic or diagnostic substance, drug, biologic, cells, etc.) or device (e.g., implantable device, sensor, electrode, etc.) to a specific location within a tissue mass (e.g., an organ, tumor, other mass of body tissue, etc.) that is located a spaced distance from an open or fluid-filled space, body cavity or body lumen.
    Type: Application
    Filed: August 25, 2008
    Publication date: February 25, 2010
    Applicant: Medtronic Vascular, Inc.
    Inventors: Jeremy Johnson, Aine Smalley
  • Patent number: D694456
    Type: Grant
    Filed: October 20, 2011
    Date of Patent: November 26, 2013
    Assignee: Cree, Inc.
    Inventors: John R. Rowlette, Jr., Jeremy Johnson